Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat

Neuroendocrinology

Volumn 77, Issue 1, 2003, Pages 44-50

  Mehta, Shyamal H ^a   Dhandapani, Krishnan M ^a   De Sevilla, Liesl M ^a   Webb, R Clinton ^a   Mahesh, Virendra B ^a   Brann, Darrell W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cortex; Gonadal steroid antagonists; Gonadal steroids; Ischemia; Selective estrogen receptor modulators; Striatum

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG IMPLANT; DRUG PELLET; DRUG SELECTIVITY; FEMALE; HEMISPHERE; IMPLANTATION; LASER DOPPLER FLOWMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; STROKE; TIMED DRUG RELEASE; TISSUE SPECIFICITY;

ANIMALS; BRAIN ISCHEMIA; DRUG EVALUATION, PRECLINICAL; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; NEUROPROTECTIVE AGENTS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 0037217490     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068332     Document Type: Article

References (38)

1. Dhandapani K, Brann DW: Protective effects of estrogen and SERMs in the brain. Biol Reprod 2002;67:1379-1385.
2. Hall ED, Pazara KE, Linserman KL: Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 1991;11:292-298.
3. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD: Gender-linked brain injury in experimental stroke. Stroke 1998;29:159-166.
4. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM: Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998;18:1253-1258.
5. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL: Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 1997;87:724-730.
6. Zhang YQ, Shi J, Rajakumar G, Day AL, Simpkins JW: Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 1998;784:321-324.
7. Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD: 17β-Estradiol reduces stroke injury in estrogen-deficient animals. Stroke 1999;30:1665-1670.
8. Shi J, Panickar KS, Yang SH, Rabbani O, Day AL, Simpkins JW: Estrogen attenuates over-expression of β-amyloid precursor protein messenger RNA in an animal model of focal ischemia. Brain Res 1998;810:87-92.
9. Dubal DB, Wise PM: Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001;142:43-48.
10. Alkayed NJ, Crain BJ, Traystman RJ, Hurn PD: Estrogen-mediated neuroprotection in reproductively senescent rats. Stroke 1999;30:274-279.
11. Brann DW, Mahesh VB: Endogenous excitatory amino acid involvement in the preovulatory and steroid-induced surge of gonadotropins in the female rat. Endocrinology 1991;128:1541-1547.
12. D'Mello D, Mehta D, Pereira J, Rao CV: A toxicity study of simultaneous administration of tamoxifen and diazepam to female Wistar rats. Exp Toxicol Pathol 1999;51:549-553.
13. Daniel CP, Gaskell SJ, Bishop H, Nicholson RI: Determination of tamoxifen and a hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometry. J Endocrinol 1979;83:401-408.
14. Delozier Y, Spielmann M, Mace-Lesec'h J, Janvier M, Hill C, Asselain B, Julien J, Weber B, Mauriac L, Petit J, Kerbrat P, Malhaire J, Vennin P, Leduc B, Namer M: Tamoxifen adjuvant treatment duration in early breast cancer: Initial results of a randomized study comparing short-term treatment with long-term treatment. J Clin Oncol 2000;18:3507-3512.
15. Jordan VC, Bain RR, Brown RR, Gosden B, Santos MA: Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer. Cancer Res 1983;43:1446-1450.
16. Zea-Longa E, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
17. Burger HG: The endocrinology of the menopause. Maturitas 1996;23:129-136.
18. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Stroke incidence, prevalence, and survival: Secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-380.
19. Mercuro G, Zoncu S, Cherchi A, Rosano G: Can menopause be considered an independent risk factor for cardiovascular disease? Ital Heart J 2001;2:719-727.
20. Kimelberg H, Feustel P, Jin Y, Paquette J, Boulos A, Keller RW, Trammer BI: Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. Neuroreport 2000;11:2675-2679.
21. Dubal D, Zhu H, Yu J, Rau S, Shughrue P, Merchenthaler I, Kindy M, Wise PM: Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 2001;98:1952-1957.
22. Toung T, Hurn P, Traystman R, Sieber F: Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus. Stroke 2000;31:2701-2706.
23. Obata T, Kubota S: Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum. Neurosci Lett 2001;308:87-90.
24. Dluzen D, McDermott JL, Anderson LI: Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice. J Neuroendocrinol 2001;13:618-624.
25. Cheng CM, Cohen M, Wang J, Bondy CA: Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J 2001;15:907-915.
26. Cyr M, Thibault C, Morissette M, Landry M, Di Paolo T: Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology 2001;25:242-257.
27. Cyr M, Morissette M, Landry M, Di Paolo T: Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors. Neuroreport 2001;12:535-539.
28. Ernst T, Chang L, Cooray D, Salvador C, Jovicich J, Walot I, Boone K, Chebowski R: The effect of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 2002;94:592-597.
29. Wu X, Glinn M, Ostrowski N, Su Y, Ni B, Cole H, Bryant H, Paul SM: Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats. Brain Res 1999;847:98-104.
30. Pinilla L, Gonzalez L, Tena-Sempere M, Aguilar E: Evidence for an estrogen-like action of raloxifene upon the hypothalamic-pituitary unit: raloxifene inhibits luteinizing hormone secretion and stimulates prolactin secretion in ovariectomized female rats. Neurosci Lett 2001;311:149-152.
31. Rossberg M, Murphy S, Traystman R, Hurn PD: LY353381.HCl, a selective estrogen receptor modulator, and experimental stroke. Stroke 2000;31:3041-3046.
32. 125I]estrogen autoradiography and non-isotopic in situ hybridization histochemistry. Brain Res 1992;576:25-41.
33. Kuppers E, Beyer C: Expression of estrogen receptor-α and -β mRNA in the developing and adult mouse striatum. Neurosci Lett 1999;276:95-98.
34. Sawada M, Alkayed N, Goto S, Crain B, Traystman R, Shaivitz A, Nelson R, Hurn PD: Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 2000;20:112-118.
35. Ahotupa M, Mantyla E, Kangas L: Antioxidant properties of the triphenylethylene antiestrogen drug toremifene. Arch Pharmacol 1997;356:297-302.
36. Kuohung W, Shwaery GT, Keaney JF Jr: Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cells. Am J Obstet Gynecol 2001;184:1060-1063.
37. Phillis JW, Song D, O'Regan MH: Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from ischemic cerebral cortex. Brain Res 1998;780:352-355.
38. Osuka K, Feustel PJ, Mongin AA, Tranmer BI, Kimelberg HL: Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J Neurochem 2001;76:1842-1850.